The type 1 Brugada ECG pattern is characterized by the documentation of a spontaneous electrocardiogram (ECG) with specific ST segment elevation in the right precordial leads (V 1 -V 3 ) and a J-point elevation of 0.2 mV in the absence or presence of sodium channel blockers ("coved type") [1, 2] . Brugada syndrome is defined as a typical ECG finding, the exclusion of a structural heart disease, and syncope or sudden cardiac death.
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We present the ECG findings of a 52-year-old man who was admitted to our center after a first episode of syncope. Invasive diagnostics ruled out a coronary heart disease, left ventricular function was normal. ECG recordings at the 4th intercostal space, which is the standard lead position (Figure 1a) , and at the 3rd intercostal space (Figure 1b A positive ajmaline test (ajmaline 1 mg/kg i.v.) showing a type 1 Brugada ECG with specific ST segment elevation in the right precordial leads (V 1 -V 3 ) with a coved type and a J-point elevation of 0.2 mV had previously been performed in the admitting hospital ( Figure 1d ) [1, 2] . After the diagnosis of a Brugada syndrome, a cardioverter defibrillator was implanted to prevent sudden cardiac death.
Recently, it has been shown that an ECG recording at a higher intercostal space in leads V 1 and V 2 had higher sensitivity than that at a standard space in these leads in unmasking and detecting a type 1 Brugada ECG. Moreover, a type 1 Brugada ECG recorded only at a higher space in leads V 1 and V 2 showed a similar prognostic value for subsequent cardiac events as that recorded at a standard space in these leads [3, 4] . Higher recordings of leads V 1 and V 2 are recommended as an alternative to drug challenge testing with sodium channel blockers, which should only be considered as next diagnostic test, if the result of higher ECG recordings is negative.
Because of the potentially life-threatening risk of the ajmaline test, it should only be performed, if an ECG at a higher intercostal space has already been recorded [4] .
